SWOT Analysis - Pfizer Essay

1366 Words6 Pages
Pfizer SWOT analysis

Pfizer is a global pharmaceutical and consumer products company, which discovers, develops, manufactures, and markets medicines for humans and animals. The company consists of three SBU's (Strategic Business Units):

• •Health Care
• •Animal Health
• •Consumer Health Care

The company produces the impotence treatment Viagra, cholesterol lowering Lipitor and, for high blood pressure and angina, Norvasc. The animal division produces treatment both for livestock and pets. The company's consumer division produces the consumer drugs Listerine, Certs, Dentyne. Pfizer engages in international business both through their subsidiaries and distributors. The company's headquarters are located in New York, US.

Pfizer
…show more content…
The company's plan of investment into research began to pay off in the 1990s. Pfizer's roster of drugs grew with the launch of Viagra (sildenafil citrate) in 1998, a treatment for erectile dysfunction. Pfizer invested close to $2.5 billion in research into the product, which quickly became a bestseller. In the year 2000, Pfizer and Warner-Lambert merged to form the new Pfizer.

SWOT Analysis
Strengths
• •R&D innovation with a broad therapeutic coverage
• •Marketing strength in major geographical and therapeutic areas
• •Patent protection for a number of years on key products
• •Using technology in improving customer relationship and business efficiency
Pfizer's strengths lie in its innovation with broad therapeutic coverage, its global marketing strength, and its key product portfolio, which remains product protected for a number of years.
Pfizer has established itself as a global provider of innovative healthcare solutions, and rather than focusing on a small number of specialist therapeutic areas, Pfizer has, instead, concentrated on product innovation in any attractive therapy area, and its current portfolio and R&D pipeline reflect this. It has strengths in a number of therapeutic areas, and its size and strong market presence is sufficient to support this diversity.

Pfizer has a global
Get Access